Magnesium Sulfate During the Postpartum in Women With Severe Preeclampsia
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
There is no evidence that patients receiving magnesium sulfate before birth are required to
maintain the drug for 24 hours. Therefore the investigators will have a randomized clinical
study in patients with severe preeclampsia who have been treated with impregnation of
magnesium sulphate and at least eight hours have received the drug before birth. If the
patient agrees and signs the consent is randomized to: 1-receive sulfate for 24 hours
postpartum as usual or, 2- not receiving the postpartum magnesium sulfate or other
anticonvulsant drugs. This study can be conducted in 12 maternity latin america.